Market Research Logo

Daewoong Pharmaceutical Co Ltd (069620) - Product Pipeline Analysis, 2018 Uate

Summary

Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, capsules, ointments, injections, liquids and sprays. It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others. The company also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. It operates across Asia including Indonesia, China, Vietnam, Thailand and India; and the US. Daewoong Pharma is headquartered in Seoul, South Korea.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Daewoong Pharmaceutical Co Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Daewoong Pharmaceutical Co Ltd Company Overview
    • Daewoong Pharmaceutical Co Ltd Company Snapshot
    • Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type
      • Table Figure 1: Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type
      • Table Daewoong Pharmaceutical Co Ltd Pipeline Products by Indication
  • Daewoong Pharmaceutical Co Ltd – Pipeline Analysis Overview
    • Business Description
    • Daewoong Pharmaceutical Co Ltd - Key Facts
      • Table Daewoong Pharmaceutical Co Ltd, Key Facts
    • Daewoong Pharmaceutical Co Ltd - Major Products and Services
      • Table Daewoong Pharmaceutical Co Ltd, Major Products and Services
    • Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage
      • Table Figure 2: Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage
      • Table Daewoong Pharmaceutical Co Ltd Number of Pipeline Products by Development Stage
      • Table Daewoong Pharmaceutical Co Ltd Pipeline Products Summary by Development Stage
    • Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status
      • Table Figure 3: Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status
      • Table Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status
      • Table Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials Summary
  • Daewoong Pharmaceutical Co Ltd Pipeline Products Overview
    • Donepezil Patch
      • Donepezil Patch Product Overview
        • Table Donepezil Patch - Product Status
        • Table Donepezil Patch - Product Description
    • Iodixanol Contrast Medium
      • Iodixanol Contrast Medium Product Overview
        • Table Iodixanol Contrast Medium - Product Status
        • Table Iodixanol Contrast Medium - Product Description
    • Ioversol Contrast Medium
      • Ioversol Contrast Medium Product Overview
        • Table Ioversol Contrast Medium - Product Status
        • Table Ioversol Contrast Medium - Product Description
    • Mediclore
      • Mediclore Product Overview
        • Table Mediclore - Product Status
        • Table Mediclore - Product Description
      • Mediclore Clinical Trial
        • Table Mediclore - A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients with Total Thyroidectomy
        • Table Mediclore - Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Axillary Dissection for Breast Cancer a Multicenter Double-blinded, Randomized Study
        • Table Mediclore - Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan (Mediclore) for Intraperitoneal Adhesion in Patient with Gynecological Surgery, a Multicenter Single-blinded, Randomized Study
        • Table Mediclore - To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Intrauterine Surgery in Patient with Gynecological Disease, a Multicenter, Randomized, Double- blinded Study
    • NOVOSIS - DENT
      • NOVOSIS - DENT Product Overview
        • Table NOVOSIS - DENT - Product Status
        • Table NOVOSIS - DENT - Product Description
    • NOVOSIS - Spinal Fusion
      • NOVOSIS - Spinal Fusion Product Overview
        • Table NOVOSIS - Spinal Fusion - Product Status
        • Table NOVOSIS - Spinal Fusion - Product Description
      • NOVOSIS - Spinal Fusion Clinical Trial
        • Table NOVOSIS - Spinal Fusion - The Clinical Study to Evaluate the Efficacy and Safety of Novosis in Posterolateral Fusion
  • Daewoong Pharmaceutical Co Ltd - Key Competitors
  • Daewoong Pharmaceutical Co Ltd - Key Employees
    • Table Daewoong Pharmaceutical Co Ltd, Key Employees
  • Daewoong Pharmaceutical Co Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Daewoong Pharmaceutical Co Ltd, Other Locations
      • Table Daewoong Pharmaceutical Co Ltd, Subsidiaries
  • Recent Developments
    • Daewoong Pharmaceutical Co Ltd, Recent Developments
      • May 26, 2016: Daewoong Bio `UDCA' passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection
      • Apr 06, 2016: Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies
      • Dec 14, 2014: Daewoong Pharmaceutical and Daewoong Bio co-participates in CPhI Worldwide
      • Dec 03, 2014: Daewoong Pharmaceutical's Ursa completed registration in Georgia
      • Nov 03, 2014: Daewoong Pharmaceutical established Liaoning Research Institute, its local research arm in China
      • Oct 24, 2014: Lee Jong-wook, President of Daewoong Pharmaceutical, was honored with the grand prize in Korea New Drug Award of Pharmaceutical Society of Korea
      • Sep 30, 2014: Daewoong Pharmaceutical rose to the position of undisputed No. 1 leader in terms of pharmaceutical production last year
      • Sep 24, 2014: Daewoong Pharmaceutical was honored with the Prize of the 'Most Trusted Company in 2014`
      • Mar 18, 2014: Daewoong Pharmaceutical rolls out `Easyderm Beauty', the spot-type wet dressing for treating the skin troubles
      • Dec 30, 2011: New-Concept Medical Equipment `Novosis' Clinical Test Started In Orthopedics In Addition To Dentistry
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report